Indication & clinical use

Each presented indication appear as a separate bullet.


For products having a product monograph, each bullet also includes the corresponding disclosures relating to clinical use from the "Indication and Clinical Use" section of the product monograph. Alternatively, this content follows the bullets if it applies to all.

i.e. considerations, conditions, or limitations relating to how to use of the product in patients who have been selected AND disclosure of data limitations (e.g. Efficacy was not evaluated beyond 8 weeks in controlled trials).

If the manufacturer elects not to include the indications in this section (i.e. as they were presented earlier), the heading would read "Clinical Use".